JULIE LEWIS: Open Payments
NPI 1093897324 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 25 payments from 16 companies in 2025. Trend: 2023 $1,099 · 2024 $1,623 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $188 |
| Boston Scientific Corporation | 1 | $153 |
| Regeneron Healthcare Solutions, Inc. | 1 | $135 |
| BridgeBio Pharma, Inc. | 2 | $133 |
| Lilly USA, LLC | 1 | $104 |
| Alnylam Pharmaceuticals Inc. | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| PFIZER INC. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: JARDIANCE, WATCHMAN, EVKEEZA, Attruby, ZEPBOUND, AMVUTTRA, LEQVIO, ELIQUIS.
Industry payments across NY — which companies pay providers there.
